Novo's Ozempic Soars As Focus Shifts To Oral Semaglutide

 
• By Kevin Grogan
  
Alarm
Novo Nordisk expecting a call soon from the FDA on oral semaglutide • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business